Screener
Novavax NVAX Total Equity
Total Equity at other companies
Other financials
Where this comes from
Reported directly by Novavax in its filing.
Tagged under the XBRL concept us-gaap:StockholdersEquity.
The source filing: Novavax’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 7:50 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001000694-26-000018
FAQ
- What is Novavax's total equity?
- Novavax (NVAX) reported total equity of -$190.71M in Q2 2026.
- How has Novavax's total equity changed year-over-year?
- Novavax's total equity decreased by 606.9% year-over-year, from $37.63M to -$190.71M.
- What is the long-term trend for Novavax's total equity?
- Over 5 years (2020 to 2025), Novavax's total equity has grown at a -27.3% compound annual growth rate (CAGR), from $627.21M to -$127.75M.
- What does total equity mean?
- Net assets attributable to shareholders — total assets minus total liabilities. Represents the book value of shareholders' ownership claim.
Ask your AI about Novavax's total equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude